Inovalon (INOV) Misses Q2 EPS by 1c

Inovalon (NASDAQ: INOV) reported Q2 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $122.06 million.

For earnings history and earnings-related data on Inovalon (INOV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c